AT383126B - Verfahren zur herstellung von neuen carbapenem-antibiotika - Google Patents
Verfahren zur herstellung von neuen carbapenem-antibiotikaInfo
- Publication number
- AT383126B AT383126B AT0125583A AT125583A AT383126B AT 383126 B AT383126 B AT 383126B AT 0125583 A AT0125583 A AT 0125583A AT 125583 A AT125583 A AT 125583A AT 383126 B AT383126 B AT 383126B
- Authority
- AT
- Austria
- Prior art keywords
- producing new
- carbapenem antibiotics
- new carbapenem
- antibiotics
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT45286A AT387388B (de) | 1982-04-08 | 1986-02-20 | Verfahren zur herstellung von neuen carbapenem-antibiotika |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36662782A | 1982-04-08 | 1982-04-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA125583A ATA125583A (de) | 1986-10-15 |
AT383126B true AT383126B (de) | 1987-05-25 |
Family
ID=23443823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0125583A AT383126B (de) | 1982-04-08 | 1983-04-08 | Verfahren zur herstellung von neuen carbapenem-antibiotika |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPS58188887A (es) |
KR (1) | KR880001055B1 (es) |
AT (1) | AT383126B (es) |
AU (1) | AU567092B2 (es) |
BE (1) | BE896407A (es) |
CA (1) | CA1198440A (es) |
CH (1) | CH661927A5 (es) |
DE (1) | DE3312517A1 (es) |
DK (1) | DK155983A (es) |
ES (1) | ES8405399A1 (es) |
FI (1) | FI74009C (es) |
FR (1) | FR2524888B1 (es) |
GB (1) | GB2118183B (es) |
GR (1) | GR78822B (es) |
HU (1) | HU190716B (es) |
IE (1) | IE55225B1 (es) |
IL (1) | IL68295A0 (es) |
IT (1) | IT1168854B (es) |
LU (1) | LU84739A1 (es) |
MY (1) | MY8700945A (es) |
NL (1) | NL8301193A (es) |
OA (1) | OA07395A (es) |
PT (1) | PT76518B (es) |
SE (1) | SE460197B (es) |
ZA (1) | ZA832411B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683301A (en) * | 1982-04-08 | 1987-07-28 | Bristol-Myers Company | Carbapenem antibiotics |
US4552696A (en) * | 1982-04-09 | 1985-11-12 | Bristol-Myers Company | Carbapenem antibiotics |
US4536335A (en) * | 1982-06-18 | 1985-08-20 | Bristol-Myers Company | Carbapenem antibiotics |
AT396473B (de) * | 1984-10-02 | 1993-09-27 | Bristol Myers Squibb Co | Verfahren zur herstellung von neuen carbapenemderivaten |
US4665169A (en) * | 1985-09-11 | 1987-05-12 | Bristol-Myers Company | Carbapenem antibiotics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU531084B2 (en) * | 1977-10-19 | 1983-08-11 | Merck & Co., Inc. | Azetidine derivatives |
EP0017992A1 (en) * | 1979-04-19 | 1980-10-29 | Merck & Co. Inc. | 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates |
EP0038869A1 (en) * | 1980-04-30 | 1981-11-04 | Merck & Co. Inc. | Process for the preparation of 1-carbapenems, and intermediates for their preparation |
HU185493B (en) * | 1981-12-30 | 1985-02-28 | Richter Gedeon Vegyeszet | Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives |
US4552696A (en) * | 1982-04-09 | 1985-11-12 | Bristol-Myers Company | Carbapenem antibiotics |
US4536335A (en) * | 1982-06-18 | 1985-08-20 | Bristol-Myers Company | Carbapenem antibiotics |
-
1983
- 1983-03-22 CA CA000424190A patent/CA1198440A/en not_active Expired
- 1983-04-01 FR FR8305431A patent/FR2524888B1/fr not_active Expired
- 1983-04-04 KR KR1019830001386A patent/KR880001055B1/ko not_active IP Right Cessation
- 1983-04-05 ZA ZA832411A patent/ZA832411B/xx unknown
- 1983-04-05 FI FI831135A patent/FI74009C/fi not_active IP Right Cessation
- 1983-04-05 NL NL8301193A patent/NL8301193A/nl not_active Application Discontinuation
- 1983-04-05 ES ES521224A patent/ES8405399A1/es not_active Expired
- 1983-04-05 IL IL68295A patent/IL68295A0/xx not_active IP Right Cessation
- 1983-04-06 AU AU13198/83A patent/AU567092B2/en not_active Ceased
- 1983-04-07 IT IT48061/83A patent/IT1168854B/it active
- 1983-04-07 GB GB08309505A patent/GB2118183B/en not_active Expired
- 1983-04-07 DK DK155983A patent/DK155983A/da not_active IP Right Cessation
- 1983-04-07 SE SE8301928A patent/SE460197B/sv not_active IP Right Cessation
- 1983-04-07 DE DE19833312517 patent/DE3312517A1/de active Granted
- 1983-04-07 PT PT76518A patent/PT76518B/pt not_active IP Right Cessation
- 1983-04-07 IE IE800/83A patent/IE55225B1/en not_active IP Right Cessation
- 1983-04-07 HU HU831201A patent/HU190716B/hu unknown
- 1983-04-07 GR GR71026A patent/GR78822B/el unknown
- 1983-04-07 LU LU84739A patent/LU84739A1/fr unknown
- 1983-04-07 BE BE0/210512A patent/BE896407A/fr not_active IP Right Cessation
- 1983-04-08 AT AT0125583A patent/AT383126B/de not_active IP Right Cessation
- 1983-04-08 CH CH1915/83A patent/CH661927A5/de not_active IP Right Cessation
- 1983-04-08 JP JP58061072A patent/JPS58188887A/ja active Granted
- 1983-04-08 OA OA57966A patent/OA07395A/xx unknown
-
1987
- 1987-12-30 MY MY945/87A patent/MY8700945A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT368161B (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika | |
AT382367B (de) | Verfahren zur herstellung von neuen azetidinverbindungen | |
AT382638B (de) | Verfahren zur herstellung von neuen trehaloselipiden | |
AT381507B (de) | Verfahren zur herstellung von neuen antibiotischen verbindungen | |
ATA206483A (de) | Verfahren zur herstellung von neuen mitosanderivaten | |
ATA125383A (de) | Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen | |
ATA1285A (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika | |
AT384612B (de) | Verfahren zur herstellung von neuen cephalosporinderivaten | |
AT382620B (de) | Verfahren zur herstellung von neuen carbapenem-derivaten | |
AT382621B (de) | Verfahren zur herstellung von neuen carbapenem-derivaten | |
AT385035B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
AT386828B (de) | Verfahren zur herstellung von neuen acylaminomitosanen | |
AT367766B (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika | |
AT383126B (de) | Verfahren zur herstellung von neuen carbapenem-antibiotika | |
AT387385B (de) | Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen | |
AT385509B (de) | Verfahren zur herstellung von neuen mitosanverbindungen | |
AT378776B (de) | Verfahren zur herstellung von neuen anthracyclinglycosiden | |
AT377980B (de) | Verfahren zur herstellung von neuen diastereomeren | |
AT387387B (de) | Verfahren zur herstellung von carbapenem-antibiotika | |
ATA45286A (de) | Verfahren zur herstellung von carbapenem-antibiotika | |
ATA373685A (de) | Verfahren zur herstellung von neuen carbapenem-derivaten | |
ATA80488A (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika | |
ATA1790A (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika | |
ATA368980A (de) | Verfahren zur herstellung von neuen aminoglykosid-antibiotika | |
ATA256085A (de) | Verfahren zur herstellung von neuen penamverbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee | ||
UEP | Publication of translation of european patent specification | ||
EEFA | Change of the company name |